Ann-Katrin Hopp

1.1k total citations · 1 hit paper
20 papers, 757 citations indexed

About

Ann-Katrin Hopp is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Ann-Katrin Hopp has authored 20 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Ann-Katrin Hopp's work include PARP inhibition in cancer therapy (9 papers), Calcium signaling and nucleotide metabolism (5 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ann-Katrin Hopp is often cited by papers focused on PARP inhibition in cancer therapy (9 papers), Calcium signaling and nucleotide metabolism (5 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ann-Katrin Hopp collaborates with scholars based in Switzerland, Germany and Austria. Ann-Katrin Hopp's co-authors include Michael O. Hottiger, Kathrin Nowak, Qiuhe Lu, Feng Shao, Wenqing Gao, B. A. McVerry, Xuyan Shi, Xiaoyun Liu, Da Li and Ping‐Kun Zhou and has published in prestigious journals such as Cell, The Lancet and Nucleic Acids Research.

In The Last Decade

Ann-Katrin Hopp

20 papers receiving 742 citations

Hit Papers

A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis th... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann-Katrin Hopp Switzerland 12 272 204 188 159 107 20 757
Daniel Grasso Argentina 19 529 1.9× 159 0.8× 539 2.9× 176 1.1× 89 0.8× 45 1.2k
E Xiaofei United States 14 337 1.2× 117 0.6× 505 2.7× 127 0.8× 34 0.3× 22 837
Michelle Hartman United States 5 518 1.9× 303 1.5× 466 2.5× 55 0.3× 68 0.6× 6 904
Francesca Demarchi Italy 19 858 3.2× 310 1.5× 484 2.6× 131 0.8× 59 0.6× 27 1.4k
Xiaojie Yan China 17 371 1.4× 122 0.6× 139 0.7× 93 0.6× 13 0.1× 42 714
Joshua L. Andersen United States 20 784 2.9× 196 1.0× 260 1.4× 144 0.9× 19 0.2× 32 1.3k
Thomas Holowka United States 9 426 1.6× 737 3.6× 218 1.2× 101 0.6× 25 0.2× 12 1.2k
Viraga Haridas United States 14 338 1.2× 354 1.7× 222 1.2× 103 0.6× 13 0.1× 22 941
Jori A. Wagenaars Netherlands 12 346 1.3× 512 2.5× 223 1.2× 112 0.7× 11 0.1× 13 925
N.M. Maurice United States 9 407 1.5× 44 0.2× 285 1.5× 77 0.5× 44 0.4× 12 842

Countries citing papers authored by Ann-Katrin Hopp

Since Specialization
Citations

This map shows the geographic impact of Ann-Katrin Hopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann-Katrin Hopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann-Katrin Hopp more than expected).

Fields of papers citing papers by Ann-Katrin Hopp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann-Katrin Hopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann-Katrin Hopp. The network helps show where Ann-Katrin Hopp may publish in the future.

Co-authorship network of co-authors of Ann-Katrin Hopp

This figure shows the co-authorship network connecting the top 25 collaborators of Ann-Katrin Hopp. A scholar is included among the top collaborators of Ann-Katrin Hopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann-Katrin Hopp. Ann-Katrin Hopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hopp, Ann-Katrin, Lorenza P. Ferretti, Lisa Schlicker, et al.. (2025). MacroD1 sustains mitochondrial integrity and oxidative metabolism. Nature Communications. 16(1). 7595–7595. 1 indexed citations
2.
Hopp, Ann-Katrin, et al.. (2024). Membrane transporters modulating the toxicity of arsenic, cadmium, and mercury in human cells. Life Science Alliance. 8(2). e202402866–e202402866. 3 indexed citations
3.
Boeszoermenyi, Andras, Xu‐Dong Chen, Felix Kartnig, et al.. (2023). A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nature Communications. 14(1). 6626–6626. 19 indexed citations
4.
Hopp, Ann-Katrin, et al.. (2023). Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD+ levels. Nucleic Acids Research. 51(17). 9248–9265. 16 indexed citations
5.
Hopp, Ann-Katrin, Federico Teloni, Kathrin Nowak, et al.. (2021). Mitochondrial NAD+ Controls Nuclear ARTD1-Induced ADP-Ribosylation. Molecular Cell. 81(2). 340–354.e5. 45 indexed citations
6.
Hopp, Ann-Katrin, Kapila Gunasekera, Roni H. G. Wright, et al.. (2021). MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation. iScience. 24(5). 102432–102432. 2 indexed citations
7.
Hopp, Ann-Katrin & Michael O. Hottiger. (2021). Investigation of Mitochondrial ADP-Ribosylation Via Immunofluorescence. Methods in molecular biology. 2276. 165–171. 3 indexed citations
8.
Hopp, Ann-Katrin & Michael O. Hottiger. (2021). Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight. Cells. 10(3). 680–680. 23 indexed citations
9.
Komuczki, Juliana, Kapila Gunasekera, Ann-Katrin Hopp, et al.. (2019). ARTD1 in Myeloid Cells Controls the IL-12/18–IFN-γ Axis in a Model of Sterile Sepsis, Chronic Bacterial Infection, and Cancer. The Journal of Immunology. 202(5). 1406–1416. 24 indexed citations
10.
Hopp, Ann-Katrin, et al.. (2019). Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation. Cells. 8(8). 890–890. 75 indexed citations
11.
Xu, Yue, Ping‐Kun Zhou, Sen Cheng, et al.. (2019). A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy. Cell. 178(3). 552–566.e20. 265 indexed citations breakdown →
12.
Lopez-Garcia, Laura A., et al.. (2018). Validation of extracellular ligand–receptor interactions by Flow-TriCEPS. BMC Research Notes. 11(1). 863–863. 1 indexed citations
13.
Hopp, Ann-Katrin, et al.. (2018). Mono-ADP-Ribosylhydrolase Assays. Methods in molecular biology. 1813. 205–213. 4 indexed citations
14.
Leutert, Mario, Stephan Menzel, Rickmer Braren, et al.. (2018). Proteomic Characterization of the Heart and Skeletal Muscle Reveals Widespread Arginine ADP-Ribosylation by the ARTC1 Ectoenzyme. Cell Reports. 24(7). 1916–1929.e5. 55 indexed citations
15.
Volohonsky, Gloria, Ann-Katrin Hopp, Julien Soichot, et al.. (2017). Transgenic Expression of the Anti-parasitic Factor TEP1 in the Malaria Mosquito Anopheles gambiae. PLoS Pathogens. 13(1). e1006113–e1006113. 51 indexed citations
16.
Hopp, Ann-Katrin, et al.. (2016). ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells. Cell Cycle. 15(15). 2042–2052. 9 indexed citations
17.
Hopp, Ann-Katrin, et al.. (2014). Self-Antigen Presentation by Dendritic Cells in Autoimmunity. Frontiers in Immunology. 5. 55–55. 41 indexed citations
18.
Isenberg, David, D J Rowe, Ann-Katrin Hopp, et al.. (1984). An immunohistological study of secondary Sjögren's syndrome.. Annals of the Rheumatic Diseases. 43(3). 470–476. 44 indexed citations
19.
McVerry, B. A., Ann-Katrin Hopp, Corinne Fisher, & E. R. Huehns. (1980). PRODUCTION OF PSEUDODIABETIC RENAL GLOMERULAR CHANGES IN MICE AFTER REPEATED INJECTIONS OF GLUCOSYLATED PROTEINS. The Lancet. 315(8171). 738–740. 68 indexed citations
20.
Mowbray, J.F., et al.. (1979). Circulating and deposited immune complexes in renal disease and their clinical correlation.. Journal of Clinical Pathology. 32(11). 1135–1139. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026